Global Impact: Chemotherapy Induced Nausea and Vomiting Drugs Market Insights and Regional Variances By 2023 to 2030
The global chemotherapy-induced nausea and vomiting (CINV) drugs market is likely to reach value at US$ 2,558.12 million in 2023 and is expected to reach US$ 4,672.82 million by 2030, growing at a CAGR of 6.6% from 2023 to 2030.
Chemotherapy-induced nausea and vomiting (CINV) is a common and debilitating side effect of cancer treatment. It can significantly impact a patient's quality of life...
0 Comentários
0 Compartilhamentos
English
French (Français)
Spanish (Español)
Arabic
Deutsch
Turkish (Türk)
Dutch (Nederlands)
Italiano
Romaian (Română)
Português (Brasil)
Greek (Ελληνικά)
Russian (русский)